Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway

Jieduquyuziyin prescription (JP) has been used to treat systemic lupus erythematosus (SLE). Although the effectiveness of JP in the treatment of SLE has been clinically proven, the underlying mechanisms have yet to be completely understood. We observed the therapeutic actions of JP in MRL/lpr mice a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Lina, Fan, Xuemin, Hou, Xiaoli, Fu, Danqing, Bao, Jie, Zhuang, Aiwen, Chen, Sixiang, Fan, Yongsheng, Li, Rongqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372094/
https://www.ncbi.nlm.nih.gov/pubmed/32760274
http://dx.doi.org/10.3389/fphar.2020.01049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372094/
https://www.ncbi.nlm.nih.gov/pubmed/32760274
http://dx.doi.org/10.3389/fphar.2020.01049

Ejemplares similares